Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus (Q28261838)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus
scientific article

    Statements

    Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus (English)
    0 references
    Carlos Manuel Corona Gutierrez
    0 references
    Alberto Tinoco
    0 references
    Tania Navarro
    0 references
    Mario López Contreras
    0 references
    Roberto Risco Cortes
    0 references
    Patricia Calzado
    0 references
    Lise Reyes
    0 references
    Roberto Posternak
    0 references
    Gianni Morosoli
    0 references
    Mauro Lara Verde
    0 references
    Ricardo Rosales
    0 references
    May 2004
    0 references
    15
    0 references
    5
    0 references
    421-31
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit